← Leaderboards
Glen D Raffel
Beth Israel Deaconess Medical Center
$4,471,484
Attributed
$4,471,484
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $514.2K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,471,484 · 5
By mechanism
R01$2,056,613 · 1
U19$1,742,976 · 3
K08$671,895 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- George C Tsokos$40,494,511
- Shalom Avraham$3,024,786
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesHematopoieticCellsStem Cell TransplantHematopoietic Stem CellsStem CellsEngraftmentInfectionRegulationPhysiologicalReagentPropertyPathway InteractionsMediatingIn VitroMegakaryocytesHematopoiesisAffectAcute Megakaryocytic LeukemiasMolecularIn VivoKnock-OutAplastic AnemiaAllogenic
Grant awards (15)
Nongenotoxic conditioning for HIV cure transplantation approaches$186,854
U19 · FY2024 · HL · contact PI
Nongenotoxic conditioning for HIV cure transplantation approaches$223,313
U19 · FY2023 · HL · contact PI
Nongenotoxic conditioning for HIV cure transplantation approaches$399,503
U19 · FY2022 · HL · contact PI
Nongenotoxic conditioning for HIV cure transplantation approaches$419,122
U19 · FY2021 · HL · contact PI
Nongenotoxic conditioning for HIV cure transplantation approaches$514,184
U19 · FY2020 · AI · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$418,750
R01 · FY2017 · HL · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$418,750
R01 · FY2016 · HL · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$412,468
R01 · FY2015 · HL · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$410,375
R01 · FY2014 · HL · contact PI
Hematopoietic regulation through Ott1-dependent alternative splicing$396,270
R01 · FY2013 · HL · contact PI
Mouse model of infant acute megakaryocytic leukemia$134,379
K08 · FY2009 · CA · contact PI
Mouse model of infant acute megakaryocytic leukemia$134,379
K08 · FY2008 · CA · contact PI
Mouse model of infant acute megakaryocytic leukemia$134,379
K08 · FY2007 · CA · contact PI
Mouse model of infant acute megakaryocytic leukemia.$134,379
K08 · FY2006 · CA · contact PI
Mouse model of infant acute megakaryocytic leukemia$134,379
K08 · FY2005 · CA